Vemurafenib in Pediatric Patients With BRAFV600E Mutated High-Grade Gliomas

被引:118
作者
Bautista, Francisco [1 ]
Paci, Angelo [2 ]
Minard-Colin, Veronique [1 ]
Dufour, Christelle [1 ]
Grill, Jacques [1 ]
Lacroix, Ludovic [3 ]
Varlet, Pascale [4 ]
Valteau-Couanet, Dominique [1 ]
Geoerger, Birgit [1 ]
机构
[1] Gustave Roussy, Pediat & Adolescent Oncol Dept, F-94805 Villejuif, France
[2] Pharmacol & Drug Anal Dept, Villejuif, France
[3] Gustave Roussy, Dept Biol Clin, F-94805 Villejuif, France
[4] Ctr Hosp St Anne, Pathol & Neurooncol Dept, Paris, France
关键词
anaplastic ganglioglioma; BRAF mutations; pediatric brain tumors; pharmacokinetics; vemurafenib; BRAF; MELANOMA; METASTASES;
D O I
10.1002/pbc.24891
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We present three pediatric patients with BRAFV600E mutant high-grade gliomas treated by vemurafenib on a nominative authorization level at our institution. One patient with anaplastic ganglioglioma experienced confirmed partial tumor response and significant clinical improvement and she is alive 20 months after start of treatment. A second patient with ganglioglioma responded transiently to re-introduction of vemurafenib after immunotherapy. Pharmacokinetic studies suggest that maximum concentration and exposure of vemurafenib at steady-state is dose-dependent and similar in children to that reported in adults. These cases suggest that BRAFV600 is an oncogenic driver in pediatric gliomas. Further exploration in clinical studies is ongoing. Pediatr Blood Cancer 2014;61:1101-1103. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:1101 / 1103
页数:3
相关论文
共 13 条
[1]  
[Anonymous], 2009, Common Terminology Criteria for Adverse Events (CTCAE). 4.0 ed
[2]   Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma [J].
Ascierto, Paolo A. ;
Minor, David ;
Ribas, Antoni ;
Lebbe, Celeste ;
O'Hagan, Anne ;
Arya, Niki ;
Guckert, Mary ;
Schadendorf, Dirk ;
Kefford, Richard F. ;
Grob, Jean-Jacques ;
Hamid, Omid ;
Amaravadi, Ravi ;
Simeone, Ester ;
Wilhelm, Tabea ;
Kim, Kevin B. ;
Long, Georgina V. ;
Martin, Anne-Marie ;
Mazumdar, Jolly ;
Goodman, Vicki L. ;
Trefzer, Uwe .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) :3205-+
[3]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[4]  
Dong JL, 2003, CANCER RES, V63, P3883
[5]   Vemurafenib [J].
Flaherty, Keith. T. ;
Yasothan, Uma ;
Kirkpatrick, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (11) :811-812
[6]   Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].
Flaherty, Keith T. ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
O'Dwyer, Peter J. ;
Lee, Richard J. ;
Grippo, Joseph F. ;
Nolop, Keith ;
Chapman, Paul B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819
[7]   Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation [J].
Haroche, Julien ;
Cohen-Aubart, Fleur ;
Emile, Jean-Francois ;
Arnaud, Laurent ;
Maksud, Philippe ;
Charlotte, Frederic ;
Cluzel, Philippe ;
Drier, Aurelie ;
Hervier, Baptiste ;
Benameur, Neila ;
Besnard, Sophie ;
Donadieu, Jean ;
Amoura, Zahir .
BLOOD, 2013, 121 (09) :1495-1500
[8]   Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation [J].
Rochet, Nicole M. ;
Dronca, Roxana S. ;
Kottschade, Lisa A. ;
Chavan, Rahul N. ;
Gorman, Brian ;
Gilbertson, Julie R. ;
Markovic, Svetomir N. .
MAYO CLINIC PROCEEDINGS, 2012, 87 (10) :976-981
[9]   Vemurafenib for Melanoma Metastases to the Brain [J].
Rochet, Nicole M. ;
Kottschade, Lisa A. ;
Markovic, Svetomir N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) :2439-2441
[10]   Brainstem Ganglioglioma Successfully Treated With Vemurafenib [J].
Rush, Sarah ;
Foreman, Nicholas ;
Liu, Arthur .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) :E159-E160